Recent advances in brain tumor-targeted nano-drug delivery systems.
about
Brain tumor-targeted drug delivery strategiesTargeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model.Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization.Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside.Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy studyThe Expression of Connexins and SOX2 Reflects the Plasticity of Glioma Stem-Like Cells.Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.D-amino acid oxidase-nanoparticle system: a potential novel approach for cancer enzymatic therapy.Plasmonics-enhanced and optically modulated delivery of gold nanostars into brain tumor.The effects of nanoparticle drug loading on the pharmacokinetics of anticancer agents.Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells.Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain gliomac(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma.Exploiting macrophages as targeted carrier to guide nanoparticles into glioma.Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment.Nanobiotechnology-based strategies for crossing the blood-brain barrier.Polymer nanocompartments in broad-spectrum medical applications.Advances in brain drug targeting and delivery: limitations and challenges of solid lipid nanoparticles.Targeted delivery of nano-therapeutics for major disorders of the central nervous system.A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.D-Peptides as Recognition Molecules and Therapeutic Agents.Harnessing nanomedicine for therapeutic intervention in glioblastoma.Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma.Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles.Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.MicroRNA in Glioblastoma: An Overview.Effect of Retro-Inverso Isomer of Bradykinin on Size-Dependent Penetration of Blood-Brain Tumor Barrier.Realizing the therapeutic potential of rare earth elements in designing nanoparticles to target and treat glioblastoma.Phytochemical based nanomedicines against cancer: current status and future prospects.L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases.Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment.Advances in Glioblastoma Multiforme Treatment: New Models for Nanoparticle Therapy.
P2860
Q26829741-17F24D9C-69F5-4F39-9DC4-215BB99504A9Q27316967-E40BE28C-9303-49C0-B748-4AA82A3979E7Q30543786-8F1D673C-AF32-40AA-8777-D531744F39EEQ31065446-F356CB3D-06A5-4ABE-A30B-1278B2A52B0FQ33829590-B86B0003-EF0A-4A9A-9152-9CC0563D83B8Q33842621-DE656BD6-4C70-4C25-A7CB-E9061AD83198Q34532194-68B653EC-E399-4EFD-8569-A984C7053669Q34577760-06428CD5-C24E-4B8D-BC59-5AE8992C7831Q35118176-EEABDAC6-B16F-4BD3-804D-7B03944B0E8AQ36126057-FC07211B-7A38-4566-AB78-95849D7DBBA8Q36630698-9FAE60A7-9E6C-4635-93B8-240FB3C8D557Q36733548-519A1C25-190C-4AF7-8E1D-9571F7BD777DQ36833586-C6A53A1D-DEF4-4803-A8AD-2DABECC20352Q37392913-FC9E646F-E709-492E-B488-B2E37F95B3F5Q37493686-AF79566B-F051-428B-AD23-0F928FC7D209Q38038895-D7891925-D368-4A54-A476-8D14D8189E93Q38087985-B3CAD54A-CE16-4DFE-AD27-B25E9BE8F4DEQ38095485-60D657BA-E0FC-4827-8B6E-F98A2C1DA5A4Q38116765-6BDDE01E-9C36-4E08-A1B2-63EE44F97770Q38830917-C19F7347-9623-4440-A91C-089CD20ADF58Q38838668-D0310E53-0623-484B-9754-343AE57E0D0CQ38851989-D4C83579-84B1-4532-9A3A-28D0D5F4C4CAQ38862946-B379C8F6-71A1-43F3-A16C-49CD8139D914Q38969029-793E0F7C-A82C-43BD-8E1F-B219A619D10DQ39025424-02B4281D-ABC4-4387-A833-F120F55D964AQ39458957-E1E8D0EF-7101-4B10-9957-4EF07D703792Q40899589-8C97FBBA-EA37-4878-B5FA-D7E5EBCF475FQ47142132-BC29977D-06CE-4C19-93E8-4142D93F56A4Q47172562-64593251-2654-4935-B968-8815F97CCAEDQ47720697-D1EFD644-A5AB-4932-BDB7-5A84387ECF17Q47829215-AF38EA90-F8F3-4211-8498-A02C509A9F2AQ48035129-E6DB8E05-39E4-4B20-91E3-F42AC9E4B7D3Q48108646-D8F75752-5A7E-4023-BBA7-24FB7940A852Q48314701-1CFB7718-1D03-4E17-ADD4-23082202EC2BQ52608753-F6F01C7E-FCBC-4FB8-B67C-27E8C341195B
P2860
Recent advances in brain tumor-targeted nano-drug delivery systems.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recent advances in brain tumor-targeted nano-drug delivery systems.
@en
type
label
Recent advances in brain tumor-targeted nano-drug delivery systems.
@en
prefLabel
Recent advances in brain tumor-targeted nano-drug delivery systems.
@en
P2860
P1476
Recent advances in brain tumor-targeted nano-drug delivery systems.
@en
P2093
P2860
P304
P356
10.1517/17425247.2012.682726
P407
P577
2012-06-01T00:00:00Z